Yuewei Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Top Venues

Cancer research

Nature communications

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Spear, Olivia Le Saux, Hasan B Mirza, Nayana Iyer, Katie Tyson, Fabio Grundland-Freile, Josephine B Walton, Chloe Woodman, Sheba Jarvis, Darren P Ennis, Carmen Aguirre Hernandez, Yuewei Xu, Pavlina Spiliopoulou, James D Brenton, Ana P Costa-Pereira, David P Cook, Barbara C Vanderhyden, Hector C Keun, Evangelos Triantafyllou, James N Arnold, Iain A McNeish
PTEN loss shapes macrophage dynamics in high grade serous ovarian carcinoma. Cancer research (2024)
Anke Nijhuis, Arti Sikka, Orli Yogev, Lili Herendi, Cristina Balcells, Yurui Ma, Evon Poon, Clare Eckold, Gabriel N Valbuena, Yuewei Xu, Yusong Liu, Barbara Martins da Costa, Michael Gruet, Chiharu Wickremesinghe, Adrian Benito, Holger B Kramer, Alex Montoya, David Carling, Elizabeth J Want, Yann Jamin, Louis Chesler, Hector C Keun
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma. Nature communications 13 (1) (2022)
Yuewei Xu, Anke Nijhuis, Hector C Keun
RNA-binding motif protein 39 (RBM39): An emerging cancer target. British journal of pharmacology (2020)